Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Recurrent kidney stones often signal excess calcium spilling into the urine, and that ongoing mineral loss can quietly thin the skeleton, raising the risk of osteopenia, osteoporosis, and fractures.
A 24-hour urine panel measures calcium, oxalate, citrate, uric acid, sodium, volume, and pH to reveal whether that calcium is coming from diet, intestinal absorption, or bone itself, which changes the treatment path. There are several important factors and result patterns to consider, so see below for the complete answer before drawing conclusions about your own risk.
Because stone pain, urinary changes, and silent bone loss can overlap with other conditions, it helps to organize your symptoms before testing or a doctor visit. Take a free, instant, online symptom check to better understand what may be driving your symptoms and what steps to take next.
Last reviewed for medical accuracy: 08/
Passing kidney stones can be painful—and if they keep coming back, it may signal an underlying issue that also affects your bones. One common culprit is hypercalciuria, a condition marked by too much calcium in your urine. Left unchecked, hypercalciuria can lead to recurrent kidney stones bone loss, increasing both stone risk and the chance of weaker bones over time. A 24-hour urine panel is a simple yet powerful tool to get to the root of the problem.
Hypercalciuria means you’re excreting more calcium in urine than normal. For context:
Why it happens:
When calcium is too concentrated in urine, it tends to combine with other substances—oxalate or phosphate—and form crystals. Over time, these crystals grow into stones. Key points:
Calcium is vital for strong bones. When too much leaves the bones into the bloodstream—and then into urine—your skeleton can suffer:
A 24-hour urine panel measures what’s in your urine over one full day. It’s the gold standard for diagnosing metabolic causes of stones and checking risk factors for bone loss.
Once you know your risk factors, you can work on a plan to reduce stones and strengthen bones:
If you’ve had more than one kidney stone, or if you’re concerned about bone health, talking to a specialist can make all the difference. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance on next steps.
Always discuss any serious symptoms or findings—like severe pain, blood in urine, or signs of bone fractures—with your doctor. Early evaluation and intervention can help you stay stone-free and maintain strong, healthy bones. Speak to a doctor about anything that could be life threatening or serious.
(References)
* Kronenberg HM. NPT2a--the key to phosphate homeostasis. N Engl J Med. 2002 Sep 26;347(13):1022-4. doi: 10.1056/NEJMe020098. PMID: 12324560.
* Caudarella R, Vescini F, Buffa A, La Manna G, Stefoni S. Osteoporosis and urolithiasis. Urol Int. 2004;72 Suppl 1:17-9. doi: 10.1159/000076585. PMID: 15133327.
* Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16;354(7):669-83. doi: 10.1056/NEJMoa055218. PMID: 16481635.
* Weaver CM. Potassium and health. Adv Nutr. 2013 May 1;4(3):368S-77S. doi: 10.3945/an.112.003533. Epub 2013 May 1. PMID: 23674806; PMCID: PMC3650509.
* Taylor EN. Stones, bones, and cardiovascular groans. Clin J Am Soc Nephrol. 2015 Feb 6;10(2):174-6. doi: 10.2215/CJN.12311214. Epub 2015 Jan 29. PMID: 25635032; PMCID: PMC4317749.
* Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie SA. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial. Lancet. 2015 Sep 19;386(9999):1147-55. doi: 10.1016/S0140-6736(15)61120-5. Epub 2015 Jul 2. PMID: 26144908; PMCID: PMC4620731.
* Tebben PJ, Singh RJ, Kumar R. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment. Endocr Rev. 2016 Oct;37(5):521-547. doi: 10.1210/er.2016-1070. Epub 2016 Sep 2. PMID: 27588937; PMCID: PMC5045493.
* Oberger Marques JV, Moreira CA. Primary hyperparathyroidism. Best Pract Res Clin Rheumatol. 2020 Jun;34(3):101514. doi: 10.1016/j.berh.2020.101514. Epub 2020 Apr 23. PMID: 32336576.
* Cormier C, Koumakis E. Bone and primary hyperparathyroidism. Joint Bone Spine. 2022 Jan;89(1):105129. doi: 10.1016/j.jbspin.2021.105129. Epub 2021 Jan 20. PMID: 33484857.
* Luo D, Xie L, Zhang J, Liu C. Exploring the association between osteoporosis and kidney stones: a clinical to mechanistic translational study based on big data and bioinformatics. Biol Direct. 2025 Mar 31;20(1):42. doi: 10.1186/s13062-025-00627-w. Epub 2025 Mar 31. PMID: 40165324; PMCID: PMC11956445.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.